Each year, the Burroughs Wellcome Fund awards up to $500,000 over five years to academic researchers as part of its Innovation in Regulatory 
Science Awards. Alison Harrill, an SOT member, is one of this year’s award recipients and will use the funding toward her work determining how genetically diverse human population will react to various drugs and chemicals. Dr. Harrill's research uses genetically diverse mice to test pharmaceutical compounds. Her research could lead to getting drugs to market more quickly, but with less risk of adverse side effects to patients.
For more information on Dr. Harrill’s award and research, view the press release on the University of Arkansas for Medical Sciences’ website. Also, please visit the In the Spotlight section of the Press page on the SOT website for updates on SOT member accomplishments. (Photo Credit: Novartis AG)